Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Bloedtesten voor Alzheimer: preciezere diagnoses en toegang tot behandeling
sep 2024 | Dementie